α-Glucosidase-IN-95

α-Glucosidase-IN-95 (Compound 21c) is a competitive α-Glucosidase inhibitor with an IC50 of 0.44 μM. α-Glucosidase-IN-95 has a significant inhibitory potency without cytotoxicity to normal cells. α-Glucosidase-IN-95 can be used for metabolic disorders like diabetes mellitus research[1].

Product Specifications

UNSPSC

12352005

Target

Glycosidase

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Metabolic Disease

Smiles

O=C(N1C[C@H](C)N(C2=NC(NC3=CC=C(Cl)C(O)=C3)=NC=C2)CC1)NC4=CC=C(C(F)(F)F)C=C4

Molecular Formula

C23H22ClF3N6O2

Molecular Weight

506.91

References & Citations

[1]Herfindo N, et al. Chiral pyrimidinyl-piperazine carboxamide derivatives as potent yeast α-glucosidase inhibitors. Sci Rep. 2025 Jul 2;15 (1) :23241.